Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

UC entrepreneur startup showcase

Event review: University of California Entrepreneur (UC) Startup Showcase


Mar 5, 2019

Holding hands with the entrepreneurs of tomorrow

Editor Thierry Heles reports from Autm’s annual meeting in Austin, Texas

Mar 5, 2019

I license, therefore I am

February 2019 issue editorial by editor Thierry Heles

Mar 5, 2019

Germany – Mittelstand forever?

Innovative region: Germany

Mar 5, 2019

New Orleans institutions prepare life sciences accelerator

Tulane University and LSU Health Sciences Center have selected New Orleans BioInnovation Center to administer life sciences accelerator services.

Mar 4, 2019

Sarepta rakes in Myonexus for $165m

Sarepta Therapeutics exercised its option to acquire Nationwide Children’s gene therapy spinout Myonexus Therapeutics after paying at least $60m for the right in May 2018.

Mar 4, 2019

Larter lands at Calgary

Stephen Larter has become Calgary’s associate vice-president for research and innovation, adding to his duties as chief scientist of the university’s CDL-Rockies accelerator for energy startups.

Mar 4, 2019

Imperial internalises tech transfer

ICL will restore internal tech transfer activities from its Imperial White City Incubator, in the process ending its arrangement with commercialisation firm IP Group.

Mar 4, 2019

Analysis: DoorDash gets $400m order

Last-mile consumer goods delivery service provider DoorDash raised $400m, from SoftBank´s Vision Fund at a valuation of $7.1bn

Mar 4, 2019

News roundup 4 March 2019

A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

Mar 4, 2019

Axial Biotherapeutics takes in $25m series B

Heritage Medical Systems has backed a $25m series B round for the Caltech spinout, which is developing therapies for Parkinson’s and Autism spectrum disorder.

Mar 1, 2019

Maze finds its way to $191m

GV and Alexandria have taken part in a $191m round to launch Maze Therapeutics with scientific co-founders from multiple universities such as Harvard and Stanford.

Mar 1, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here